Observations placeholder
Temozolomide
Identifier
020191
Type of Spiritual Experience
Background
A description of the experience
Temozolomide, (TMZ) (brand names Temodar and Temodal and Temcad) is an oral chemotherapy drug. It is an alkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.
On Dec, 28, 2016 4,752 people reported to have side effects when taking Temozolomide. Among them, 9 people (0.19%) have Hallucination
Time on Temozolomide when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Feb, 11, 2016: 2,791 people reported to have side effects when taking Temozolomide. Among them, 69 people (2.47%) have Death.
Time on Temozolomide when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 65.00% | 30.00% | 5.00% | 0.00% | 0.00% | 0.00% | 0.00% |